Unknown

Dataset Information

0

Self-efficacy in Insomnia Symptom Management after Digital CBT-I Mediates Insomnia Severity during the COVID-19 Pandemic.


ABSTRACT:

Study objectives

Digital cognitive behavioral therapy for insomnia (dCBT-I) can reduce acute insomnia and depressive symptoms and prevent symptom recurrence. The current study evaluated self-efficacy in managing insomnia symptoms as a potential mediator of the relationship between prior dCBT-I and subsequent insomnia and depressive symptoms assessed during the coronavirus 2019 (COVID-19) pandemic.

Method

Participants were 208 adults who completed a randomized controlled trial of dCBT-I versus sleep education in 2016-2017 and also completed self-report assessments of insomnia, depression, and self-efficacy in managing insomnia symptoms. Data were collected in May 2020, five weeks into state-wide COVID-19 stay-at-home orders. Regression and mediation analyses were used to evaluate the extent to which self-efficacy accounted for the relationship between treatment condition and improvement in insomnia and depressive symptoms from pre-treatment to COVID-19 follow-up.

Results

Prior dCBT-I predicted greater self-efficacy in managing insomnia symptoms. Self-efficacy accounted for 49% and 67% of the protective effect of dCBT-I against COVID-era insomnia and depressive symptoms, respectively.

Conclusions

This study affirms the importance of self-efficacy as a key intervention outcome and potential mechanism by which dCBT-I predicts future sleep and mental health. Future studies that evaluate the role of self-efficacy in treatment effectiveness and resilience can provide additional clues about how to optimize dCBT-I for maximum benefit to public health.

SUBMITTER: Cheng P 

PROVIDER: S-EPMC8917241 | biostudies-literature | 2022 Sep-Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Self-efficacy in Insomnia Symptom Management after Digital CBT-I Mediates Insomnia Severity during the COVID-19 Pandemic.

Cheng Philip P   Casement Melynda D MD   Kalmbach David A DA   Cuamatzi Castelan Andrea A   Drake Christopher L CL  

Behavioral sleep medicine 20210912 5


<h4>Study objectives</h4>Digital cognitive behavioral therapy for insomnia (dCBT-I) can reduce acute insomnia and depressive symptoms and prevent symptom recurrence. The current study evaluated self-efficacy in managing insomnia symptoms as a potential mediator of the relationship between prior dCBT-I and subsequent insomnia and depressive symptoms assessed during the coronavirus 2019 (COVID-19) pandemic.<h4>Method</h4>Participants were 208 adults who completed a randomized controlled trial of d  ...[more]

Similar Datasets

| S-EPMC10764726 | biostudies-literature
| S-EPMC10804384 | biostudies-literature
| S-EPMC11744252 | biostudies-literature
| S-EPMC8483157 | biostudies-literature
| S-EPMC10757200 | biostudies-literature
| S-EPMC4488337 | biostudies-other
| S-EPMC7861359 | biostudies-literature
| S-EPMC6688754 | biostudies-literature
| S-EPMC11808919 | biostudies-literature